USPTO serial 79035160
CEVEC
Reviewed by CopyMark Law Group
Reg. 3405717Status 706Registered
- Filing date
- Status date
- Registration date
- Apr 1, 2008
- Examiner
- KUNG, KAELIE ELIZABETH
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with CEVEC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dyan M. House
Dyan M. House Baker & Mckenzie, LLP1900 N. Pearl Street, Suite 1500Dallas, TX 75201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes and biological products for scientific purposes in the nature of [ microorganisms, ] eukaryotic cell culture lines, polypeptides, proteins, nucleic acids, viral vectors and gene expression vectors, except for medical and veterinary purposes; chemical and biological preparations other than for medical or veterinary purposes, for use in research and characterization of diseases, namely, diagnostic preparations for scientific and research use; [ cultures of microorganisms for scientific purposes, ] eukaryotic cell culture lines for scientific purposes | ACTIVE | — |
| 005 | [ Medicaments for the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases; pharmaceutical and veterinary preparations for use in the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases; ] chemical and biological preparations for medical use, namely, for medical diagnosis and analysis; eukaryotic cell culture lines, [ microorganisms, ] polypeptides, nucleic acids for medical and medical diagnostic purposes | ACTIVE | — |
| 042 | Scientific and industrial research and consulting services, in particular in the fields of molecular biology, biotechnology, genetics; pharmaceutical research and development; medical research and development of methods of medical therapy; scientific and technological services in the nature of breeding, recovery, optimization, synthesis and modification of eukaryotic cell culture lines, [ micro-organisms, ] polypeptides, nucleic acids for third parties; research services in the fields of medicine and pharmaceuticals; [ medical and scientific research, namely, conducting clinical trials for third parties ] | ACTIVE | — |
| 044 | Medical and veterinary services; medical services, namely, breeding, recovery, optimization, synthesis and modification of eukaryotic cell culture lines, [ micro-organisms, ] polypeptides, nucleic acids for third parties; consulting services in the fields of medicine and pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CEVEC Pharmaceuticals GmbH
- Other trademarks owned by CEVEC Pharmaceuticals GmbH
- Other trademarks owned by CEVEC Pharmaceuticals GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CEVEC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 9, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 9, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 9, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 9, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 9, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 9, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 19, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 21, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 21, 2023 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Aug 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 21, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 21, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 13, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 13, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 13, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 11, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 11, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 11, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 11, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 19, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 11, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 11, 2018 | INPC | INVALIDATION PROCESSED | — |
| Aug 23, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 17, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 23, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Dec 23, 2017 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Dec 9, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 27, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 15, 2017 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 17, 2016 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 11, 2014 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED | — |
| Apr 11, 2014 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 11, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 10, 2014 | 715F | REGISTERED - SEC. 71 & SEC. 15 FILED | — |
| Mar 10, 2014 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Dec 22, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 17, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 17, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 3, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 1, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 15, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 26, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 11, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 10, 2007 | ALIE | ASSIGNED TO LIE | — |
| Nov 2, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 10, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 12, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 12, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 11, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 10, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 30, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 29, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |